An Act relative to copay assistance for medications

This bill requires pharmaceutical manufacturers to offer copay assistance programs for both branded and generic medications to all Massachusetts residents, regardless of their insurance status (unless federal law prohibits it). It mandates that manufacturers notify the Department of Public Health about program details and eligibility, and the Department must make this information publicly available to patients and healthcare providers. The law directly affects patients struggling with medication costs and pharmaceutical manufacturers operating in Massachusetts. Key provisions ensure transparency and access without restricting participation by manufacturers.